Jamie E. Fegan

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Rationally designed minimized TbpB confers broad protection against meningococcal infection.

Rationally designed minimized TbpB confers broad protection against meningococcal infection.

Journal: PLoS pathogens

Published: January 28, 2026

Rationally designed minimized TbpB confers broad protection against meningococcal infection.

Rationally designed minimized TbpB confers broad protection against meningococcal infection.

Journal: PLoS pathogens

Published: January 28, 2026

Structure-based engineering of a nutrient acquisition protein enhances neutralizing antibodies and protection for the development of a gonococcal vaccine.

Structure-based engineering of a nutrient acquisition protein enhances neutralizing antibodies and protection for the development of a gonococcal vaccine.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Rationally designed minimized TbpB confers broad protection against meningococcal infection.

Rationally designed minimized TbpB confers broad protection against meningococcal infection.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection.

Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection.

Journal: mSphere

Published: April 16, 2025

Meningococcal vaccine Bexsero elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection.

Meningococcal vaccine Bexsero elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection.

Journal: bioRxiv : the preprint server for biology

Published: September 24, 2024

Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria.

Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria.

Journal: bioRxiv : the preprint server for biology

Published: September 24, 2024

Human transferrin and lactoferrin cooperatively support Neisseria meningitidis colonization in the murine nasopharynx.

Human transferrin and lactoferrin cooperatively support Neisseria meningitidis colonization in the murine nasopharynx.

Journal: bioRxiv : the preprint server for biology

Published: September 16, 2024

Rational selection of TbpB variants elucidates a bivalent vaccine formulation with broad spectrum coverage against Neisseria gonorrhoeae.

Rational selection of TbpB variants elucidates a bivalent vaccine formulation with broad spectrum coverage against Neisseria gonorrhoeae.

Journal: bioRxiv : the preprint server for biology

Published: September 16, 2024

Rational selection of TbpB variants yields a bivalent vaccine with broad coverage against Neisseria gonorrhoeae.

Rational selection of TbpB variants yields a bivalent vaccine with broad coverage against Neisseria gonorrhoeae.

Journal: NPJ vaccines

Published: September 07, 2024

Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria.

Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria.

Journal: Vaccine

Published: September 07, 2024

Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of Pasteurella multocida in cattle.

Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of Pasteurella multocida in cattle.

Journal: Frontiers in immunology

Published: February 27, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026